Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin kappa variable 2D-18 pseudogene (IGKV2D-18) is a member of the immunoglobulin kappa variable (IGKV) gene family, located within the immunoglobulin kappa locus (IGK) at chromosome 2p11.2[8][9]. The IGKV gene family encodes the variable domain of the kappa light chains of immunoglobulins (antibodies), which are crucial for antigen recognition, through the process of V-J rearrangement during B cell development[1][3][5][9]. IGKV2D-18 is annotated as a pseudogene, meaning it is a DNA sequence similar to a functional gene but is not translated into a functional protein product—usually due to mutations or lack of essential coding segments[2][4][9]. As such, it does not have a known protein product, is not considered a therapeutic target, and is not directly implicated in disease or used as a biomarker. Alternative names include A13 and IGKV2D18[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin kappa variable 2D-18 pseudogene (IGKV2D-18).